Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Neoplasms by Site 1Neoplasms 1Lung Diseases 1

Interventions

Cisplatin 4atezolizumab 3Nivolumab 3Carboplatin 3pembrolizumab 2entrectinib 2cobimetinib 2capmatinib 2alectinib 2abemaciclib 2Vemurafenib 2Radiosurgery 2Pemetrexed 2Mitomycin 2Fulvestrant 2Drug Therapy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2spartalizumab 1ribociclib 1repotrectinib 1relatlimab 1relacorilant 1pertuzumab 1palbociclib 1olaparib 1lutetium Lu 177 dotatate 1exemestane 1enzalutamide 1enfortumab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasms by Site × Telescopes × Clear all
NCT07165691 2025-12-02

TELESCOPE-H

Rutgers, The State University of New Jersey

Phase NA Recruiting
91 enrolled
Thoracic

Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡